Novartis AG (VIE:NOVN)

Market Cap	239.18B
Revenue (ttm)	48.05B
Net Income (ttm)	12.27B
Shares Out	n/a
EPS (ttm)	6.22
PE Ratio	19.50
Forward PE	16.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4
Average Volume	1
Open	122.00
Previous Close	122.46
Day's Range	122.00 - 122.12
52-Week Range	94.21 - 122.50
Beta	n/a
RSI	73.81
Earnings Date	Feb 4, 2026

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: NOVN

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD